What does GHK-Cu mean?
GHK is a peptide made of three amino acids: glycine, histidine and lysine. It can bind copper; the resulting complex is called GHK-Cu, hence copper peptide. Interest includes its effects on cells involved in skin maintenance and repair. [41]
An ingredient's presence alone does not show how the entire product will work. Other ingredients, preparation methods and whether it is applied to skin or administered differently matter. A study of one cream does not assess every product with that name.
Why is collagen discussed?
Collagen is one of the components that give tissues strength. In an older experiment, GHK-Cu increased its production in cultured fibroblasts, cells that make components of connective tissue. This is an important lead for researchers. However, it is not direct evidence that a cosmetic product removes wrinkles or speeds wound healing in humans. [41]
Many steps lie between a cellular response and a visible skin effect. Research must establish, among other things, whether the ingredient reaches its intended site and whether the observed change matters to the product's user.
What did human studies show?
A small study of skin care after laser treatment found no objective advantage of GHK-Cu in the skin features assessed, although participants using it were more satisfied. This illustrates the difference between a person's own assessment and a measured outcome. [42]
Details of the post-laser study
Thirteen people completed the study and were followed for 12 weeks. Assignment to skin care with or without GHK-Cu was random. No significant advantage was found in objectively assessed redness, wrinkles or overall skin quality. The small sample limits confidence in the conclusions. We read the abstract. [42]
An August 2026 paper reported improvement in some skin measures after a cream containing GHK-Cu and a bacterial ferment. There was no control group, so the peptide's own contribution is unknown. [43]
A separate small study in 2026 concerned eyebrows. Its findings suggested a small local benefit, but do not establish treatment of scalp hair loss. [44]
Does information about a cream also apply to injections?
They cannot be transferred automatically. The FDA highlights limited safety data for injectable GHK-Cu and the possibility of immune reactions related to product quality. How often these problems occur is not well known. [45]
The TGA also highlights general risks of unapproved peptide preparations, including uncertain contents and sterility. A label does not replace product testing. However, these warnings should not be presented as findings from studies of every cosmetic containing GHK-Cu. [53]
Does GHK-Cu have proven rejuvenating effects?
The studies described do not establish whole-body rejuvenation or life extension. Even a favourable result for skin appearance answers a much narrower question.
In May 2026, FDA returned GHK-Cu, excluding injections, to the category of ingredients considered for pharmacy compounding. This is a US administrative assessment step, not drug approval or confirmation of advertising claims. [46]
Where are the more recent results?
GHK-Cu: what do new cosmetic studies tell us? — we discuss two 2026 publications and show how to assess their limitations.
Where does this information come from?
Show sources and how they were checked
- Maquart et al.: GHK-Cu and collagen production in cell culture
Laboratory study · 1988 · abstract reviewed · DOI: 10.1016/0014-5793(88)80509-x. Accessed: 2 November 2026.
- Miller et al.: skin care with GHK-Cu after laser treatment
Small randomised study · 2006 · abstract read · DOI: 10.1001/archfaci.8.4.252. Accessed: 02.11.2026.
- Wang i wsp.: krem z fermentem i GHK-Cu
Study of a multi-ingredient preparation · 10.08.2026 · full text without the separate DOCX supplement · DOI: 10.1111/srt.70360. Accessed: 02.11.2026.
- Bo et al.: topical GHK-Cu and eyebrow density
Conference publication · 22 May 2026 · abstract, methods, results and limitations in the PDF. Accessed: 2 November 2026.
- FDA: risks associated with substances used in pharmacy compounding
US regulator · accessed 2 November 2026 · injectable GHK-Cu entry and table context. Accessed: 2 November 2026.
- TGA: niezatwierdzone produkty peptydowe
Australian regulator · 13.04.2026 · main announcement text. Accessed: 02.11.2026.
- FDA: substances nominated for the 503A list
US regulator · updated 14 May 2026 · pages 1–3, GHK-Cu excluding injection routes. Accessed: 2 November 2026.